Research progress of axillary de-escalation management after neoadjuvant chemotherapy for clinical lymph node positive patients
In the era of effective systemic therapy and precise radiotherapy, neoadjuvant treatment (NAT) for breast cancer can de-escalate breast cancer treatment to conserve breast and spare axillary lymph node dissection (ALND). At present, high axillary nodal pathologic complete response (apCR) is achieved...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Editorial Office of China Oncology
2023-02-01
|
| Edice: | Zhongguo aizheng zazhi |
| Témata: | |
| On-line přístup: | http://www.china-oncology.com/thesisDetails#10.19401/j.cnki.1007-3639.2023.02.011 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
